Abstract
MBA-15, a marrow stromal-derived cell line, was shown to express an estrogen receptor. This finding was confirmed by in situ hybridization and receptor binding assay. An exposure to estrogen (10-12-10-6M) in a dose response manner resulted in a decrease of cell proliferation as measured by MTT assay. Cell function was measured by enzymatic activities of two osteoblastic markers, CD1O/NEP and alkaline phosphatase. These enzymatic activities were elevated following the estrogen treatment. This model enabled direct evaluation of the estrogen effect on stroma osteoblast cells.
Original language | English |
---|---|
Pages (from-to) | 401-405 |
Number of pages | 5 |
Journal | Cell Biology International |
Volume | 20 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1996 |
Keywords
- Bone marrow
- Estrogen receptor
- Osteoblasts